

CLASSIFICATION: GROWTH HORMONE RELEASING HORMONE ANALOG
ACTIVE SUBSTANCE: MODIFIED GRF 1-29
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROXIMATELY 30 MINUTES
DOSAGE: 100-300 MCG 1-3 TIMES DAILY
ACNE: RARE
WATER RETENTION: LOW
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE REPORTED
AROMATIZATION: DOES NOT CONVERT TO ESTROGEN
MANUFACTURER: PEPTIDE HUBS
Experience the power of precise growth hormone stimulation with Peptide Hubs' CJC-1295 No DAC 5mg. This advanced peptide, also known as Modified GRF 1-29, represents the cutting edge of growth hormone-releasing hormone (GHRH) analogs. Unlike its DAC-bound counterpart, CJC-1295 No DAC provides rapid, pulsatile growth hormone release that closely mimics the body's natural secretion patterns without extended activity.
CJC-1295 No DAC is a modified version of the native Growth Hormone-Releasing Hormone (GHRH) fragment comprising the first 29 amino acids. The modification includes the replacement of the second amino acid (alanine) with aspartic acid, significantly enhancing stability and bioavailability while maintaining full biological activity. This precise modification creates a peptide resistant to dipeptidyl peptidase IV degradation, extending its half-life compared to the native GHRH (1-29) while preserving the natural pulsatile release pattern.
According to research published in the National Institutes of Health, GHRH analogs like Modified GRF 1-29 stimulate growth hormone secretion through specific pituitary receptors, activating the cAMP pathway and ultimately increasing both GH production and release. This mechanism produces a physiological pulse pattern that differs from the non-pulsatile, sustained elevation seen with long-acting GHRH analogs or exogenous growth hormone administration.
Mimics the body's natural growth hormone secretion pattern for physiological results with minimal side effects.
Promotes lipolysis and reduces adipose tissue, particularly stubborn abdominal fat, without catabolic effects.
Accelerates recovery between training sessions through enhanced protein synthesis and cellular repair.
When administered before bedtime, increases deep sleep phases and maximizes natural nocturnal GH pulses.
For those seeking complementary peptides, consider our GHRP-2 which offers powerful growth hormone releasing effects through a different mechanism of action.
Reconstitute the lyophilized powder with bacteriostatic water before administration. The typical dosage ranges from 100-300 mcg, administered 1-3 times daily. Due to its short half-life (approximately 30 minutes), timing is crucial for optimal results. Most users experience best outcomes with administration on an empty stomach—upon waking, pre-workout, and especially before bedtime to coincide with the body's natural nocturnal growth hormone surge. Avoid administering immediately after meals as elevated blood glucose can blunt the growth hormone response.
For optimal results, consider pairing with our Sterile Bacteriostatic Water (10ml) which provides the ideal solvent for peptide reconstitution and preservation.
Typical cycles range from 8-12 weeks, followed by a 4-week break to prevent receptor desensitization. Most users report noticeable improvements in recovery and sleep quality within the first 1-2 weeks, with visible body composition changes becoming apparent within 4-6 weeks. For enhanced results, CJC-1295 No DAC can be effectively stacked with growth hormone secretagogues (GHSs) that work through different mechanisms.
Consider combining with Ipamorelin for a powerful growth hormone-releasing combination that mimics natural secretion patterns, or with Mechano Growth Factor (MGF) for targeted muscle repair and localized growth stimulation.
Important: This product is intended for research purposes only. Not for human consumption. Always consult with a healthcare professional before beginning any new supplement regimen.
Our CJC-1295 No DAC undergoes rigorous third-party testing to ensure >99% purity, accurate peptide sequencing, and complete sterility. Each batch is manufactured in ISO-certified facilities using pharmaceutical-grade ingredients and advanced lyophilization technology. The result is a premium peptide product that delivers consistent, measurable results for serious athletes and researchers.
For those interested in other research compounds, explore our Epitalon for telomere support and cellular health, or our LL-37 for immune system modulation and antimicrobial research.
Peptide Hubs remains committed to providing the highest quality research peptides to the scientific community. Our CJC-1295 No DAC represents the pinnacle of peptide technology, offering researchers a precise tool for studying growth hormone dynamics without the extended activity profile of DAC-modified analogs.
The primary difference lies in their half-lives and release profiles. CJC-1295 with DAC (Drug Affinity Complex) binds to albumin in the bloodstream, extending its half-life to approximately 7-10 days and creating sustained GH release. CJC-1295 No DAC (Modified GRF 1-29) has a short half-life of about 30 minutes, producing brief, pulsatile GH releases that closely mimic the body's natural secretion pattern. The No DAC version allows for more precise timing of GH pulses and avoids the continuous elevation seen with the DAC version.
The most effective administration times are on an empty stomach—typically upon waking, pre-workout, and especially before bedtime. The pre-bedtime administration is particularly important as it coincides with the body's natural nocturnal growth hormone surge. Avoid administering immediately after meals (wait 2-3 hours post-meal) as elevated blood glucose and insulin levels can blunt the growth hormone response. Due to its short half-life, timing is more critical with CJC-1295 No DAC than with longer-acting peptides.
Yes, CJC-1295 No DAC is frequently and effectively combined with growth hormone secretagogues (GHSs) like GHRP-6, GHRP-2, or Ipamorelin. These combinations create a synergistic effect as they work through different mechanisms—CJC-1295 No DAC stimulates GH release through GHRH receptors, while GHSs work through ghrelin receptors. This dual approach often produces a greater GH release than either compound alone. Many users report excellent results with a 100-300 mcg dose of each peptide administered simultaneously.
Users typically notice improved sleep quality and enhanced recovery within the first 1-2 weeks. Visible fat loss, especially around the abdominal area, becomes apparent within 4-6 weeks. Full cycle results include significantly improved muscle definition, reduced body fat, enhanced recovery between workouts, improved skin texture and elasticity, and increased lean muscle mass. The pulsatile nature of CJC-1295 No DAC means it produces more natural, physiological results compared to sustained-release compounds.
CJC-1295 No DAC is generally well-tolerated with an excellent safety profile. Some users report temporary flushing, lightheadedness, or tingling sensations shortly after injection—these typically subside within 30 minutes. Unlike traditional GH therapy or long-acting GHRH analogs, CJC-1295 No DAC does not cause water retention, joint pain, or carpal tunnel syndrome due to its pulsatile release pattern. The modified structure also reduces potential histamine responses compared to some other peptides.
Please log in to write CJC 1295 NO DAC 5 MG review.
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: CJC-1295 DAC
FORM: POWDER - 2 ML VIAL x 5 MG
ACTIVE HALF-LIFE: ~ 6-8 days
DOSAGE: 500 - 1000 MCG, 2-3X PER WEEK
ACNE: RARE
WATER RETENTION: MINIMAL
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: DRAGON PHARMA
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (rHGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 PRE-FILLED PEN x 36 IU (12 MG)
ACTIVE HALF-LIFE: ~3.5 HOURS (SUBQ)
DOSAGE: 1–4 IU/DAY FOR ANTI-AGING; 4–8 IU/DAY FOR FAT LOSS OR PERFORMANCE
WATER RETENTION: POSSIBLE (DOSE DEPENDENT)
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PFIZER
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (r-hGH)
ACTIVE SUBSTANCE: SOMATROPIN (R-HGH)
FORM: 1 CARTRIDGE x 15 MG
ACTIVE HALF-LIFE: ~2–3 HOURS
DOSAGE: MEN 4-10 IU/DAY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): MAY INCREASE VIA FLUID RETENTION
HEPATOTOXICITY: NONE TYPICAL
AROMATIZATION: NONE
MANUFACTURER: NOVO NORDISK
CLASSIFICATION: GONADOTROPIN (LH RECEPTOR AGONIST)
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 LYOPHILIZED VIAL x 5000 IU + PROVIDED SOLVENT
ACTIVE HALF-LIFE: ~24–36 HOURS
DOSAGE: MEN 500-1000 IU
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): MONITOR IF AT CV RISK
HEPATOTOXICITY: NONE TYPICAL
AROMATIZATION: INDIRECT
MANUFACTURER: IBSA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 ML AMP x 5000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: MODERATE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: PRE-MIXED HUMAN CHORIONIC GONADOTROPIN
FORM: 1 VIAL x 10000 IU (READY-TO-INJECT)
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW to MODERATE
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY INCREASES ESTROGEN
MANUFACTURER: BHARAT SERUMS AND VACCINES
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: PRE-MIXED HUMAN CHORIONIC GONADOTROPIN
FORM: 1 VIAL x 5000 IU (READY-TO-INJECT)
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW to MODERATE
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY INCREASES ESTROGEN
MANUFACTURER: BHARAT SERUMS AND VACCINES
CLASSIFICATION: NATURAL HORMONE
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 AMP [2 ML PER AMP] x 10000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3 TIMES/WEEK (ON-CYCLE OR PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NO
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMACEUTICALS